Linezolid manifests a rapid and dramatic therapeutic effect for patients with life-threatening tuberculous meningitis

Feng Sun, Qiaoling Ruan, Jiali Wang, Shu Chen, Jialin Jin, Lingyun Shao, Ying Zhang, Wenhong Zhang

Research output: Contribution to journalArticle

Abstract

We conducted a retrospective cohort study of patients with MRC grade II/III tuberculous meningitis (TBM) who accepted a background antitubercular regimen (BR) with or without linezolid (LZD). At the 4th week, the LZD-BR group achieved a faster and higher percentage of Glasgow coma scale recovery and temperature recovery, a higher cerebrospinal fluid (CSF)/blood glucose ratio, and lower CSF white blood cell counts than did the BR group. Short-term linezolid supplementation may be a more effective treatment for life-threatening TBM.Copyright

Original languageEnglish (US)
Pages (from-to)6297-6301
Number of pages5
JournalAntimicrobial agents and chemotherapy
Volume58
Issue number10
DOIs
StatePublished - Oct 1 2014

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Linezolid manifests a rapid and dramatic therapeutic effect for patients with life-threatening tuberculous meningitis'. Together they form a unique fingerprint.

  • Cite this